Evidence map›Paper›PMID 35755988›Full record

ReviewAustralian prescriber2022

Hormonal contraception and mood disorders.

Eveline Mu, Jayashri Kulkarni

Erratum issuedAbstract readReview
In one paragraph

Review in Australian prescriber, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Do sex and gender matter in the pharmacological treatment of depression?Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Contraception and Mood Effects-Psychopharmacology bulletin · 2025
    Article
  14. Article
  15. The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Estrogen and psychosis - a review and future directions.Archives of women's mental health · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Eveline MuMonash Alfred Psychiatry Research Centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne.ORCID https://orcid.org/0000-0002-5261-849X
Jayashri KulkarniMonash Alfred Psychiatry Research Centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne.ORCID https://orcid.org/0000-0002-3875-5623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hormonal contraception is known to precipitate or perpetuate depression in some patients. The link between oral contraceptive pills and depression relates to the amount and type of progestogen contained in these pills. Many of the older oral contraceptive pills, which contain ethinylestradiol, are linked to severe mood problems. Newer oral contraceptive pills containing physiological forms of oestrogen may be better tolerated with a purported weaker link to mood problems. Clinicians should consider the temporal relationship between the use of hormonal contraception and development of new or worsened depression or mood changes.

Indexed as

moodoestrogenoral contraceptive pillprogesteroneprogestogen

Identifiers

PMID35755988
PMCPMC9218393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.